Form 8.3

Summary by AI BETAClose X

Qube Research disclosed an opening position in Tate & Lyle as at 06-11-2026 showing 0 direct ordinary shares (0.00%), 7,223,882 cash-settled derivative exposures representing 1.62% and 505,988 short positions representing 0.11%; the 09-11-2026 filing details multiple equity-swap transactions (notably increasing a long position by 250,000 at 561.00 GBp and increasing a short by 5,048 at 561.00, with reductions including 30,796 at 561.00), confirms no stock-settled derivatives or subscription rights, states no indemnities or related arrangements, and indicates no Supplemental Form 8 attached.

Disclaimer*

Companies

Tate & Lyle (TATE)
UK 100